Ming Yan is CHIEF TECHNOLOGY OFFICER of Cytek Biosciences, Inc.. Currently has a direct ownership of 6.02 Million shares of CTKB, which is worth approximately $32.4 Million. The most recent transaction as insider was on May 18, 2022, when has been sold 2,642 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.02M
0.19% 3M change
0.39% 12M change
Total Value Held $32.4 Million

Ming Yan Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 18 2022
BUY
Exercise of conversion of derivative security
-
2,642 Added 0.03%
8,125,445 Common Stock
Apr 19 2022
SELL
Open market or private sale
$206,800 $10.34 p/Share
20,000 Reduced 0.25%
8,122,803 Common Stock
Mar 21 2022
SELL
Open market or private sale
$232,800 $11.64 p/Share
20,000 Reduced 0.25%
8,142,803 Common Stock
Mar 07 2022
BUY
Exercise of conversion of derivative security
$43,076 $0.59 p/Share
73,011 Added 0.89%
8,162,803 Common Stock
Feb 22 2022
SELL
Open market or private sale
$268,800 $13.44 p/Share
20,000 Reduced 0.25%
8,089,792 Common Stock
Feb 10 2022
SELL
Open market or private sale
$303,800 $15.19 p/Share
20,000 Reduced 0.25%
8,109,792 Common Stock
MY

Ming Yan

CHIEF TECHNOLOGY OFFICER
Fremont, CA

Track Institutional and Insider Activities on CTKB

Follow Cytek Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

News

Receive news related to Cytek Biosciences, Inc.

Track Activities on CTKB